Skip to content

Severity of RSV Infections in Twins

Phenotype Severity of RSV-infections in Twins During the First Year of Life

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05070975
Acronym
TwinSeVeRS
Enrollment
94
Registered
2021-10-07
Start date
2021-11-05
Completion date
2022-01-27
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, RSV Infection

Keywords

RSV infections in twins, Bronchiolitis, very-severe-LRTI, severe-LRTI, LRTI, upper respiratory tract infection, RSV infection, Human, infant

Brief summary

Respiratory syncytial virus (RSV) infection is the most common cause of severe lower respiratory tract infection (LRTI) in the pediatric population worldwide. Age at the time of infection, prematurity, multiparity, exposure to smoke and the level of passive immunity transmitted at birth are the main risk factors for lower respiratory infection associated with RSV. Other factors, including the innate immune response, respiratory microbiota, and intra-host viral heterogeneity, may also affect outcomes but are not fully considered in RSV infection. Exploring the impact of these factors is difficult due to the heterogeneity of the population which makes statistical adjustment difficult. Thus, twin models are useful in understanding the impact of the host on the environment, as twins often share similar exposure to infection and many risk factors, but not all are ie different prenatal and postnatal conditions, differential transfer of maternal antibodies and the genetic makeup of heterozygotes.

Interventions

OTHEREpidemiology

Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 354 Days
Healthy volunteers
No

Inclusion criteria

* Twins born at Hospices Civils de Lyon in the years 2012 to 2020 * At least one twin hospitalized with positive RSV-PCR during the first year of life

Exclusion criteria

* Major differential underlying disease between twins * Death of a twin before the RSV epidemic period of the first year of life * Nosocomial infection * Lack of understanding of the study or questionnaire by parents * Lack of parental consent

Design outcomes

Primary

MeasureTime frameDescription
Percentage of discordant twin pairs in severity of Respiratory Syncytial Virus infections.1 dayThe primary outcome measure is the percentage of discordant twin pairs of at least one severity level on the WHO (World Health Organization) scale. The discrepancy in the level of severity is obtained by retrospective analysis of the data from the medical file.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026